» Articles » PMID: 20874852

Intra- and Inter-laboratory Variability in Human T-cell Leukemia Virus Type-1 Proviral Load Quantification Using Real-time Polymerase Chain Reaction Assays: a Multi-center Study

Overview
Journal Cancer Sci
Specialty Oncology
Date 2010 Sep 30
PMID 20874852
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Human T-cell leukemia virus type-1 (HTLV-1) proviral load (VL) is an important determinant of viral pathogenesis and malignant evolution. Although VL has been quantified by in-house real-time quantifiable polymerase chain reaction (qPCR) technology, little is known about the harmonization among different VL assay systems. We evaluated intra- and inter-laboratory variability of VL measured at six laboratories using the same DNA samples seropositive for HTLV-1 in a two-step manner. The first study measured 60 samples by original in-house assays, finding that the median intra- and inter-laboratory coefficient of variation (CV) was 44.9% (range, 25.4-71.8%) and 59.9% (34.2-93.4%), respectively. The inter-laboratory correlation coefficients ranged from 0.760 to 0.875, indicating that VL were measured with good precision in each laboratory, but inter-laboratory regression slopes differed from 0.399 to 2.206, indicating that VL were measured with a wide variation between laboratories. To examine the effect of standardization of reference materials (RM) on the VL variability, we performed a second study using only 20 samples by substituting RM for plasmid including the HTLV-1 pX region. The median inter-laboratory CV for raw pX copy number was reduced significantly from 66.9% to 35.7%, whereas the median CV for the internal control remained almost unchanged, resulting in no improvement in inter-laboratory CV for VL. This indicates that each in-house assay system worked well with good precision, but standardizing RM alone was insufficient for harmonization. The relevant choice of not only RM, but also internal control genes for data normalization is expected to be realistic to standardize HTLV-1 VL measurement.

Citing Articles

Development and Validation of Multiplex Quantitative Real-Time PCR Assays for Simultaneous Detection and Differentiation of HTLV-1 and HTLV-2, Using Different PCR Platforms and Reagent Brands.

Goncalves M, Fukasawa L, Campos K, Takenori Higa F, Caterino-de-Araujo A Front Microbiol. 2022; 13:831594.

PMID: 35369428 PMC: 8965094. DOI: 10.3389/fmicb.2022.831594.


Brazilian Protocol for Sexually Transmitted Infections 2020: human T-cell lymphotropic virus (HTLV) infection.

Rosadas C, Brites C, Arakaki-Sanchez D, Casseb J, Ishak R Rev Soc Bras Med Trop. 2021; 54(suppl 1):e2020605.

PMID: 34008723 PMC: 8210483. DOI: 10.1590/0037-8682-605-2020.


Tocilizumab has no direct effect on cell lines infected with human T-cell leukemia virus type 1.

Endo Y, Fukui S, Koga T, Sasaki D, Hasegawa H, Yanagihara K J Int Med Res. 2021; 49(3):3000605211002083.

PMID: 33745335 PMC: 7989142. DOI: 10.1177/03000605211002083.


HTLV-1 targets human placental trophoblasts in seropositive pregnant women.

Tezuka K, Fuchi N, Okuma K, Tsukiyama T, Miura S, Hasegawa Y J Clin Invest. 2020; 130(11):6171-6186.

PMID: 33074247 PMC: 7598071. DOI: 10.1172/JCI135525.


Establishment of a novel diagnostic test algorithm for human T-cell leukemia virus type 1 infection with line immunoassay replacement of western blotting: a collaborative study for performance evaluation of diagnostic assays in Japan.

Okuma K, Kuramitsu M, Niwa T, Taniguchi T, Masaki Y, Ueda G Retrovirology. 2020; 17(1):26.

PMID: 32831150 PMC: 7444053. DOI: 10.1186/s12977-020-00534-0.


References
1.
Bustin S, Benes V, Garson J, Hellemans J, Huggett J, Kubista M . The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem. 2009; 55(4):611-22. DOI: 10.1373/clinchem.2008.112797. View

2.
Nagai M, Yamano Y, Brennan M, Mora C, Jacobson S . Increased HTLV-I proviral load and preferential expansion of HTLV-I Tax-specific CD8+ T cells in cerebrospinal fluid from patients with HAM/TSP. Ann Neurol. 2002; 50(6):807-12. DOI: 10.1002/ana.10065. View

3.
Asquith B, Bangham C . Quantifying HTLV-I dynamics. Immunol Cell Biol. 2007; 85(4):280-6. DOI: 10.1038/sj.icb.7100050. View

4.
Tanaka G, Okayama A, Watanabe T, Aizawa S, Stuver S, Mueller N . The clonal expansion of human T lymphotropic virus type 1-infected T cells: a comparison between seroconverters and long-term carriers. J Infect Dis. 2005; 191(7):1140-7. DOI: 10.1086/428625. View

5.
Kamihira S, Dateki N, Sugahara K, Hayashi T, Harasawa H, Minami S . Significance of HTLV-1 proviral load quantification by real-time PCR as a surrogate marker for HTLV-1-infected cell count. Clin Lab Haematol. 2003; 25(2):111-7. DOI: 10.1046/j.1365-2257.2003.00503.x. View